Market Insights Health OTC Pharmaceuticals

Analgesics - Sweden

Sweden

In Sweden, the revenue in the Analgesics market reached US$229.90m in 2024.
It is projected to experience an annual growth rate of 4.85% (CAGR 2024-2029).
When compared to other countries worldwide, the in the United States generates the highest revenue with US$7,243.00m in 2024.
In terms of per capita figures, in Sweden generates US$21.54 in revenue per person in 2024.
The demand for natural and herbal analgesics is on the rise in Sweden as consumers prioritize holistic and sustainable health solutions.

Key regions: Canada, United States, United Kingdom, Australia, Germany

Market

Region

Region comparison

Currency

Analyst Opinion

The Analgesics market in Sweden has been experiencing steady growth in recent years.

Customer preferences: Swedish consumers have shown a strong preference for over-the-counter analgesics, such as ibuprofen and paracetamol, due to their convenience and accessibility. These products are widely available in pharmacies, supermarkets, and convenience stores, making them easily accessible to consumers. Additionally, Swedish consumers are increasingly seeking out natural and organic analgesic products, reflecting a growing trend towards health and wellness. This has led to an increase in the demand for herbal and homeopathic analgesics in the market.

Trends in the market: One of the key trends in the Analgesics market in Sweden is the growing demand for non-opioid pain relief options. This trend can be attributed to several factors, including concerns about the addictive nature of opioid-based analgesics and a desire for milder, non-addictive alternatives. As a result, there has been an increase in the sales of non-opioid analgesics, such as non-steroidal anti-inflammatory drugs (NSAIDs) and acetaminophen.Another trend in the market is the rising popularity of online sales channels. Swedish consumers are increasingly turning to online platforms to purchase analgesics, as it offers convenience and a wider range of products to choose from. This shift towards online purchasing has prompted both traditional retailers and pharmaceutical companies to invest in e-commerce platforms and online marketing strategies to capture this growing segment of the market.

Local special circumstances: Sweden has a well-developed healthcare system that provides affordable and accessible healthcare to its citizens. This has contributed to a high level of health awareness among the population, leading to a greater demand for analgesics. Additionally, the country has a high rate of musculoskeletal disorders, such as arthritis and back pain, which has further fueled the demand for analgesics.

Underlying macroeconomic factors: Sweden has a stable and prosperous economy, which has contributed to the growth of the Analgesics market. The country has a high disposable income and a strong social welfare system, which allows consumers to afford and prioritize their healthcare needs. Furthermore, the aging population in Sweden has also played a role in the growth of the market, as older individuals are more likely to require analgesics for pain management.In conclusion, the Analgesics market in Sweden is experiencing steady growth, driven by customer preferences for over-the-counter products, the demand for non-opioid pain relief options, the rise of online sales channels, and the country's well-developed healthcare system and stable economy. These factors are expected to continue driving the growth of the market in the coming years.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.